Lightcalls.com
 

The cupful of coffee that helps mi...

The cupful of coffee that helps millions of populace get started in the morning--plus several more bowls throughout the day--may help abate the risk of diabetes, Dutch researchers say. inferences of a surprising new application of mind indicate that coffee drinkers are half as likely to bring to maturity adult onset diabetes, also known as symbol 2 diabetes.

couple scientists at Vrije University in Amsterdam said composings in coffee seem to help the corpse metabolize sugar, thereby reducing the risk of diabetes, which affects 130 million persons worldwide.

The reflection has caused quite a stir because caffeine is known to change into the body's sensitivity to insulin, the hormone that diabetics ne to treat their condition. on the other hand caffeine itself may not be the diabetes link. It could be other constituents in coffee--such as potassium, magnesium, chlorogenic acid and other micronutrients--that help obstruct diabetes. In fact, the scientists recommend further studies may find that decaffeinated coffee provides the same benefit without the caffeine.

"This is the first cogitation that suggests that coffee could be beneficial for exemplar 2 diabetes, whether it's filter, cappuccino, latte or espresso" says rook van Dam, PhD, of the university's department of nutrition and health. The more coffee race drink, the lower their risk. family who drink seven or more lots of coffee a day are 50 percent les likely to bring to maturity diabetes than those who don't drink coffee



That doesn't mean that clan should drink large amounts of coffee each day. Studies have shown that drinking too frequently coffee can raise cholesterol of the same heights and increase the risk of osteoporosis in an people, according to van Dam.

if it were not that if scientists knew more about the active ingredients in coffee, it might be possible to make a image of coffee, or a similar returns with more of the beneficial combines and fewer of the detrimental ones

The application of mind was announced in the November 9 2002 edition of the British medical journal The Lancet.

COPYRIGHT 2003 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2003 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.